高级检索
当前位置: 首页 > 详情页

Effects and risks of 3.2-mm transparent corneal incision phacoemulsification for cataract after radial keratotomy

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol, Beijing Tongren Hosp, 17 Hougou Lane, Beijing 100005, Peoples R China [2]Beijing Key Lab Ophthalmol & Visual Sci, 17 Hougou Lane, Beijing 100005, Peoples R China [3]Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Key Lab Ophthalmol & Visual Sci, Beijing Tongren Hosp, Beijing, Peoples R China [4]Univ Calif San Diego, Jacobs Retina Ctr, Shiley Eye Inst, La Jolla, CA 92093 USA [5]Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Peoples R China
出处:
ISSN:

关键词: Radial keratotomy cataract transparent corneal incision phacoemulsification intraocular lens wound dehiscence

摘要:
Objective This study was performed to analyze the visual outcomes and complications of phacoemulsification using a 3.2-mm transparent corneal incision in eyes with cataract after radial keratotomy (RK). Methods We retrospectively reviewed cases of lens phacoemulsification and intraocular lens implantation after RK. The main measurement results were postoperative best-corrected visual acuity (BCVA), endothelial cell density, and complications. Results Overall, 19 eyes of 12 patients with 8 (n = 6), 12 (n = 7), and 16 (n = 6) RK cuts were included in the study. Intraoperative wound dehiscence occurred in two eyes with 16 RK cuts. Successful phacoemulsification with intraocular lens implantation was performed in all eyes. The mean BCVA at the last follow-up (0.19 +/- 0.13 LogMAR) was significantly better than the preoperative BCVA (0.72 +/- 0.54 LogMAR). However, there was a significant reduction in the corneal endothelial cell density after surgery (2384.0 +/- 833.4/mm(2) vs. 1716.95 +/- 906.79/mm(2)). Conclusions Surgeons should be aware of the risk of wound dehiscence in patients who undergo phacoemulsification after RK. A small transparent corneal incision or scleral tunnel incision is recommended.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
JCR分区:
出版当年[2018]版:
Q4 PHARMACOLOGY & PHARMACY Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol, Beijing Tongren Hosp, 17 Hougou Lane, Beijing 100005, Peoples R China [2]Beijing Key Lab Ophthalmol & Visual Sci, 17 Hougou Lane, Beijing 100005, Peoples R China
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol, Beijing Tongren Hosp, 17 Hougou Lane, Beijing 100005, Peoples R China [2]Beijing Key Lab Ophthalmol & Visual Sci, 17 Hougou Lane, Beijing 100005, Peoples R China [*1]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital of Capital Medical University [*2]Beijing Key Laboratory of Ophthalmology & Visual Sciences, No. 17 Hougou Lane, Dongcheng District, Beijing 100005, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:25479 今日访问量:0 总访问量:1499 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)